Digital Therapeutics Should Have More to Come in Healthcare by 2023 | AMCP Nexus 2022

October 13, 2022

Kelly Price, vice president of market access for Mahana Therapeutics, compared the difference between digital therapeutics, prescription digital therapeutics and how FDA approval factors into that difference. She also shared what's hopeful and what's to come as far as coverage decisions, rule changes and FDA guidance for digital therapeutics in 2023.